The cost of drugs from Canada is set to soar for millions of Americans because of a federal rule

Millions of Americans who purchase inexpensive medications from Canadian pharmacies could face higher costs and difficulties accessing their prescriptions due to a forthcoming U.S. customs rule change. This development has drawn opposition from both Democrats and some Republicans, as the cost of living remains a pressing concern for voters leading up to the midterm elections.

The rule targets the de minimis exemption, which previously permitted shipments valued under $800 to enter the U.S. more readily. Beginning October 22, this exemption will be indefinitely suspended, and medications shipped from abroad will require additional information and a bond guarantee. This change will affect a wide range of goods beyond drugs, but the most significant impact will likely be felt by those who rely on affordable drugs purchased from Canada.

According to a 2020 study by JAMA Network, approximately 2.3 million Americans buy their medications from Canadian pharmacies. Critics argue that the rule could exacerbate the already high costs of healthcare and deny patients access to essential medicines. Susan Hooper, a 75-year-old Toledo, Ohio resident who requires oxygen and takes two daily medications imported from Canada, expressed concern about the rule's impact on her life.

The Trump administration has prioritized lowering drug prices as part of its healthcare strategy, with the president having negotiated most-favored-nation deals with pharmaceutical companies and launched the discounted-drug website TrumpRx. However, federal data from this summer indicates that U.S. prescription drug prices have decreased by 3.1% from the previous year, a drop that is largely attributed to factors beyond the administration's control.

Ken Hunter, executive director of the Campaign for Personal Prescription Importation, advocates for Americans who access Canadian drugs and warns that costs will likely skyrocket following the rule's implementation. He cited Eliquis, a blood thinner commonly used to prevent and treat blood clots, as an example, noting that a three-month supply would cost $565 from a Canadian pharmacy, compared to $1,017 from Amazon's pharmacy or $1,029 from GoodRx.

The White House spokesperson, Allison Schuster, reaffirmed the Trump administration's commitment to lowering prescription drug costs, citing ongoing efforts to ensure Americans have access to low-cost pharmaceuticals. However, lawmakers from both parties have called for answers on how the administration will protect patients' access to affordable care, particularly those who rely on medications purchased from Canada.